21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer. — المؤلف: Geyer, Charles E — NPJ breast cancer 2018
- المؤلف
- Geyer, Charles E
- النشر
- NPJ breast cancer 2018
- الوصف
- 37 p.